Moderate to Severe Papulopustular Rosacea
2 clinical trials · Condition
◉ Watch Moderate to Severe Papulopustular Rosacea
| Record | Firm | Date |
|---|---|---|
| Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea (NCT03050086) | BioPharmX, Inc. | 2017-03-29 |
| Clinical Endpoint Study of Ivermectin 1% Cream (NCT02840461) | Actavis Inc. | 2016-06-01 |
Track Moderate to Severe Papulopustular Rosacea automatically
Every clearance here is in the API, with alerts when new ones post.